- Home
- HSCS
as 07-26-2024 4:00pm EST
Heart Test Laboratories Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | SOUTHLAKE |
| Market Cap: | 2.7M | IPO Year: | 2022 |
| Target Price: | N/A | AVG Volume (30 days): | 129.3K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -48.00 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.40 - $98.00 | Next Earning Date: | 09-12-2024 |
| Revenue: | $18,600 | Revenue Growth: | 100.02% |
| Revenue Growth (this year): | 1074.49% | Revenue Growth (next year): | 3104.05% |
Latest Heart Test Laboratories Inc. News
HSCS Breaking Stock News: Dive into HSCS Ticker-Specific Updates for Smart Investing
GlobeNewswire
11 hours ago
Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency
GlobeNewswire
a day ago
HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare
GlobeNewswire
15 days ago
HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction
GlobeNewswire
2 months ago
HeartSciences Regains Compliance with Nasdaq Listing Requirements
GlobeNewswire
2 months ago
HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio
GlobeNewswire
3 months ago
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG
GlobeNewswire
4 months ago
HeartSciences to Present at the LD Micro Invitational XIV Conference
GlobeNewswire
4 months ago
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients
Compare HSCS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HSCS Heart Test Laboratories Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.